NCT00198289View on ClinicalTrials.gov

Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

June 30, 2006

Conditions
Staphylococcus Aureus
Interventions
DRUG

Aurexis® (tefibazumab)

Trial Locations (1)

30322

Emory University, Atlanta

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY